The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Logic of Scientific Discovery
(2013) · A Realist Theory of Science · doi:10.4324/9780203090732-9 · Cited by 7,731
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
Gottesman, I. I., & Gould, T. D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.636 · Cited by 5,615
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
Grace, A. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90196-u · Cited by 1,831
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685 · cited 2×
“It was subsequently proposed that schizophrenia may be related to a deficient glutamate mediated excitatory neurotransmission via N-methyl D-aspartate (NMDA) receptors (Moghaddam, 2003; Olney and Farber, 1995).”
BackgroundThe neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Cited by
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
Self-citationStructural dynamics of dendritic spines in memory and cognition
Kasai, H., Fukuda, M., Watanabe, S., Hayashi-Takagi, A., & Noguchi, J. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.01.001 · Cited by 804
Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence
Savla, G. N., Vella, L., Armstrong, C. C., Penn, D. L., & Twamley, E. W. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs080 · Cited by 736
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Self-citationEvidence of a dimensional relationship between schizotypy and schizophrenia: A systematic review
Nelson, M. T., Seal, M. L., Pantelis, C., & Phillips, L. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.01.004 · Cited by 334
Bossong, M. G., & Niesink, R. J. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.010 · Cited by 333
What Do We Know About Neuropsychological Aspects Of Schizophrenia?
Palmer, B. W., Dawes, S. E., & Heaton, R. K. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9109-y · Cited by 316
Hippocampal Volume Reduction in First-Episode and Chronic Schizophrenia: A Review and Meta-Analysis
Adriano, F., Caltagirone, C., & Spalletta, G. (2012) · The Neuroscientist · doi:10.1177/1073858410395147 · Cited by 285
New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis
Yang, A., & Tsai, S.-J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081689 · Cited by 282
Pillinger, T., D’Ambrosio, E., McCutcheon, R., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0058-9 · Cited by 230
“For the metareview focussing on CNS dysfunction, we focused on metaanalyses of parameters previously identified in an expert review as key neurobiological alterations seen in schizophrenia [37], covering alterations in brain structure, neurophysiology, and neurochemistry.”
MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia
Lai, C.-Y., Yu, S.-L., Hsieh, M. H., Chen, C.-H., Chen, H.-Y., Wen, C.-C., Huang, Y.-H., Hsiao, P.-C., Hsiao, C. K., Liu, C.-M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021635 · Cited by 228
“Although the underlying pathophysiology of schizophrenia remains not well understood, dysregulations of its susceptibility genes are likely to converge functionally upon illness risk [5], which may manifest as certain endophenotypes, such as abnormalities in sustained attention, executive function, or eventrelated pot…”
BackgroundEndophenotypes in schizophrenia: A selective review
Allen, A. J., Griss, M. E., Folley, B. S., Hawkins, K. A., & Pearlson, G. D. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.016 · Cited by 210
“…mainly on SCZ and REL, with little data on HC. Recent articles, such as the “Just the Facts” series in this journal (Tandon et al., 2008 a, b; Keshavan et al. 2008), have brought to light the importance of evaluating endophenotypes for schizophrenia in order to assess research progress in…”
BackgroundStubbs, B., Thompson, T., Acaster, S., Vancampfort, D., Gaughran, F., & Correll, C. U. (2015) · Pain · doi:10.1097/j.pain.0000000000000304 · Cited by 141
“First, impaired prefrontal and medial temporal functioning in schizophrenia [33] may”
BackgroundVancampfort, D., Probst, M., Helvik Skjaerven, L., Catalán-Matamoros, D., Lundvik-Gyllensten, A., Gómez-Conesa, A., Ijntema, R., & De Hert, M. (2012) · Physical Therapy · doi:10.2522/ptj.20110218 · Cited by 141
Neurobiological effects of physical exercise in schizophrenia: a systematic review.
Vancampfort, D., Probst, M., De Hert, M., Soundy, A., Stubbs, B., Stroobants, M., & De Herdt, A. (2014) · Disability and Rehabilitation · doi:10.3109/09638288.2013.874505 · Cited by 80
Hutcheson, N. L., Sreenivasan, K. R., Deshpande, G., Reid, M. A., Hadley, J., White, D. M., Ver Hoef, L., & Lahti, A. C. (2015) · Human Brain Mapping · doi:10.1002/hbm.22714 · Cited by 79
Preclinical Behavioral Models for Predicting Antipsychotic Activity
Castagné, V., Moser, P. C., & Porsolt, R. D. (2009) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)57010-4 · Cited by 64
Altered evoked gamma-band responses as a neurophysiological marker of schizophrenia?
Lenz, D., Fischer, S., Schadow, J., Bogerts, B., & Herrmann, C. S. (2011) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2010.08.002 · Cited by 37
Orešič, M., Seppänen-Laakso, T., Sun, D., Tang, J., Therman, S., Viehman, R., Mustonen, U., van Erp, T. G., Hyötyläinen, T., Thompson, P., et al. (2012) · Genome Medicine · doi:10.1186/gm300 · Cited by 5
“Several theories have been proposed to conceptualize the pathological processes inherent to schizophrenia, among others altered neurotransmission, autoimmune dysfunction and dysregulation of inflammation [1,2].”
Background
Metadata
- Authors
- KESHAVAN, M., TANDON, R., BOUTROS, N., & NASRALLAH, H.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 106
- Issue
- 2-3
- Pages
- 89-107
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2070140643
- Cited by
- 347
- References
- 233
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.